« Back to main page

Sort list by presenter     ·    by title     ·    by ID number     ·    search by keyword

Click abstract title for more information
The poster Click abstract title to view poster icon indicates a Virtual Poster can be viewed online

Displaying all abstracts in category:
Genitourinary Cancer

1081: Magnetic Resonance Lymphography with Ferumoxtran-10 for Pelvic Lymph Node Target Delineation in Bladder and Prostate Cancer
Dinniwell, Robert
1082: IMRT Improves Pelvic Lymph Node (PLN) Coverage and Dose to Critical Structures Compared with Standard Four Field (4F) Whole Pelvis (WP) Radiation Therapy (RT) in Prostate Cancer (PC)
Wang-Chesebro, Alice
1083: The Clinical Impact of Local Radiation Therapy and the Percentage of Positive Lymph Nodes in Prostate Cancer PatientsTreated with Hormonal Therapy
Lee, Andrew
1084: Real Time Prostate Translation, Rotation, Deformation Evaluated with Calypso Beacon
Burch, Douglas Click abstract title to view poster
1085: Intra-Fraction Prostate Motion Using MV Fluoroscopy
Lometti, Michael
1086: Ultrasound vs. Seed Marker Prostate Localization
Scarbrough, Todd Click abstract title to view poster
1087: Clinical Experience With The Calypso
Kupelian, Patrick Click abstract title to view poster
1088: Assessing the Utility of a 2-Year Post Treatment Biopsy for Forecasting Eventual Biochemical Failure and Survival
Vance, Waseet
1089: How Reliable are Electronic Biochemical Failure Algorithms? An Examination of the Variability of Results from Four Centers
Williams, Scott
1090: Changing Definitions of Biochemical Failure after External Beam Radiotherapy for Localized Prostate Cancer: Effect on Outcome Analyses
Reddy, Chandana Click abstract title to view poster
1091: First Year PSA Kinetics and Nadirs after Prostate Cancer Radiotherapy are Predictive of Overall Survival
Cheung, Rex
1092: The Percentage of Positive Cores is not an Appropriate Risk Factor for Prostate Radiotherapy to
Buyyounouski, Mark
1093: Dosimetric Quantifiers for Low Dose Rate Prostate Brachytherapy: V100 is Superior to D90
Papagikos, Michael
2096: Bicalutamide 150 mg in Addition to Standard Care Delays Progression to Bone Metastases in Patients with LocallyAdvanced Prostate Cancer: Analyses from the Second Analysis of the Early Prostate Cancer Program
See, William Click abstract title to view poster
2097: Predictors of Rectal Acute Toxicity in High-Dose 3D-CRT for Prostate Cancer. Results from a Prospective Multi-Centric Study Performed by the AIRO National Working Group on Prostate Irradiation
Valdagni, Riccardo
2098: Adjuvant Androgen Deprivation Therapy Offers a "CURE" in Patients with Poor Prognosis Non-Metastatic Prostate Cancer
Fleshner, Neil Click abstract title to view poster
2099: 20 Gy versus 44 Gy Supplemental Beam Radiation with Pd-103 Prostate Brachytherapy: Early Biochemical Outcomes froma Prospective Randomized Multi-Center Trial
Orio, Peter
2100: Biochemical Relapse-Free Survival After High Dose External Radiotherapy (
Reuther, Alwyn Click abstract title to view poster
2101: Late Toxicity and Early Prostate-Specific Antigen Outcome Following Salvage Prostate Brachytherapy For Select PatientsFollowing Primary Radiation Therapy
Suh, W. Warren
2102: Salvage Prostate Brachytherapy Following Radiotherapy Failure
Lo, Kathy
2103: Comparison of Two Fractionation Schedules for Conformal Radiation Therapy for Prostate Cancer
Mahadevan, Arul
2104: Prostate Specific Antigen Half-Life Following Salvage Radiation Therapy for an Isolated PSA Elevation After Radical Prostatectomy
Buskirk, Steven Click abstract title to view poster
2105: Biologically Effective Dose Values for Prostate Brachytherapy: Effects on PSA Failure and Post-Treatment Biopsy Results
Stock, Richard
2106: Preoperative PSA Velocity Predicts for Relapse after Radical Prostatectomy
King, Christopher
2107: Increased Risk of Biochemical and Local Failure in Patients with Distended Rectum on the Planning CT for Prostate Cancer Radiotherapy
de Crevoisier, Renaud
2108: Dose-Volume Determinants of Late Genitourinary Toxicity after External Beam Radiotherapy for Prostate Cancer
Alcantara, Pino
2109: VEGF-D Expression Predicts Biochemical Outcome in Localized Prostate Cancer Treated with External Radiation: a Ten Year Cohort Analysis
Bermudez, Scott
2110: Analysis of Biochemical Failure Definitions Based on Absolute and Current Nadir Methodologies and Their Integration with Prostate-Specific Antigen (PSA) Doubling Time
Kestin, Larry Click abstract title to view poster
2111: Predictors of Hormone Refractory Disease in Men Treated with Salvage Androgen Deprivation following Definitive Radiotherapy for Prostate Cancer
Hanlon, Alexandra
2112: Iodine 125 Brachytherapy for Favorable Risk Prostate Cancer: Results for 509 Patients. When Can We Start to Trust PSA after Brachytherapy?
Crook, Juanita
2113: Phase II Trial of External Radiotherapy, Brachytherapy, Androgen Deprivation and Docetaxel Chemotherapy for High-Risk, Localized Prostate Cancer
DiBiase, Steven
2114: Match Pair Analysis of Prostate Cancer Patients at risk of Positive Pelvic Lymph Nodes >15% Treated to High Radiation Doses With and Without Pelvic EBRT
Boike, Thomas
2115: Long-term Prostate Cancer Control (13 Year Actuarial) in Patients with a High Likelihood of Extracapsular Cancer Extension Using PD-103 Brachytherapy and Supplemental Beam Radiation
Dattoli, Michael Click abstract title to view poster
2116: Prostate Brachytherapy In Twenty-Four Patients With Inflammatory Bowel Disease
Peters, Christopher Click abstract title to view poster
2117: Efficacy Of Neoadjuvant Dutasteride And Bicalutamide As A Cytoreductive Regimen Prior To Permanent Interstitial Brachytherapy
Anderson, Richard
2118: Prostate Brachytherapy-Induced Urethral Strictures
Butler, Wayne
2119: Sustained Long-term Immune Responses Following In Situ Gene Therapy Combined with Radiotherapy and Hormonal Therapy in Prostate Cancer Patients
Fujita, Tetsuo
2120: Defining the Rectal Dose Constraint for Permanent Radioactive Seed Implantation of the Prostate
Albert, Michele
2121: Percent Positive Cores and Proportion Cancer Volume as Prognostic Factors for Prostate Radiation Therapy
Ray, Michael
2122: Clinical Implication of PSA Bounce after Treatment of Prostate Cancer with Brachytherapy and/or External Beam Radiotherapy with or without Androgen Deprivation
Antonucci, J
2123: Intraprostatic Fiducials for Localization of the Prostate Gland: Monitoring Intermarker Distances During Radiation Therapy to Test for Marker Stability
Maach, Mourad Click abstract title to view poster
2124: Time Course of Recovery of Serum Testosterone following Short Course Neo Adjuvant LHRH Analogue and Radical Radiotherapy in Localised Prostate Cancer
Murthy, Vedang
2125: Combined Prostate Brachytherapy and Short-Term Androgen Deprivation Therapy as Salvage Treatment for Patients with Locally Recurrent Prostate Cancer after External Beam Irradiation
Wong, William
2126: Outcome Assessment Using Hazard Ratios for Intermediate and High Risk Prostate Cancer Patients Treated with Accelerated Hypofractionated High Dose Radiation without Androgen Deprivation
Galalae, Razvan
2127: Interstitial High Dose Rate (HDR) Brachytherapy for Early Stage Prostate Cancer
Mark, Rufus Click abstract title to view poster
2128: Daily Electronic Portal Imaging of Implanted Gold Seed Fiducials in Patients Undergoing Salvage Radiotherapy After Radical Prostatectomy
Schiffner, Daniel
2129: Study of Lymphatic Drainage by SPECT-CT Fusion Images for Pelvic Irradiation of Prostate Cancer
Krengli, Marco
2130: Interim Results of a Phase II Dose Escalating Trial with Image Guided Adaptive Radiotherapy for the Treatment of Early toHigh Risk Prostate Cancer Patients: Improved Outcome with Increased EBRT Doses
Martinez, Alvaro
2131: Salvage Brachytherapy for the Prostate: Correlation of MR/MRS Imaging and the Pre-Salvage Biopsy for Locally Recurrent Carcinoma of the Prostate
Wallace, Timothy Click abstract title to view poster
2132: Prostate Position Variability and Dose-Volume-Histograms in Radiotherapy for Prostate Cancer with Full and Empty Bladder
Pinkawa, Michael Click abstract title to view poster
2133: Adaptive Radiotherapy for Invasive Bladder Cancer, a Feasibility Study
Pos, Floris
2134: Comparison of the ASTRO Consensus Definition versus the Houston/Current PSA Nadir + 2 Definition of Biochemical Failure in Prostate Cancer Patients Undergoing Permanent Iodine-125 Brachytherapy
Linstadt, David Click abstract title to view poster
2135: Daily Megavoltage CT Imaging in Patients with Prostate Cancer Receiving Postoperative Radiation Therapy: Does the Prostate Bed Move?
Burkavage, Robert Click abstract title to view poster
2136: Daily Dose Recalculation using Megavoltage CT Images During Tomotherapy for Localized Prostate Cancer: Dosimetric Analysis for the Prostate Gland, Rectum and Bladder for the Full Treatment Course
Zeidan, Omar Click abstract title to view poster
2137: Defining Biochemical Control after Prostate Brachytherapy: Can We Use a Target PSA?
Coen, John
2138: Debulking Prostatectomy for cT4 Prostate Cancer: Role of Adjuvant Therapy
Johnstone, Peter Click abstract title to view poster
2139: Men with Intermediate Risk Prostate Cancer with a History of Transurethral Resection of Prostate (TURP) have a Higher Risk of Biochemical Failure
D'Ambrosio, David
2140: The Relationship of International Prostate Symptom Score with Urinary Flow Studies, and Catheterization Rates following Iodine 125 Prostate Brachytherapy
Martens, Chandra Click abstract title to view poster
2141: A Phase II Study of Imatinib Mesylate In Prostate Cancer Patients With Evidence of Biochemical Relapse Following Definitive Radical Retropubic Prostatectomy or Radiation Therapy
Bajaj, Gopal
2142: IMRT versus Conventional Whole Pelvis Radiotherapy for Prostate Cancer: Planning Comparison and Analysis of Acute Toxicity
Su, Andy
2143: Interstitial High Dose Rate (HDR) Brachytherapy + IMRT vs. HDR Monotherapy for Early Stage Prostate Cancer
Neumann, Thomas Click abstract title to view poster
2144: Role of Pelvic Lymphadenectomy (PL) and Adjuvant Androgent Deprivation (AAD) in Patients Treated with Radical Prostatectomy (RP) and Early Adjuvant RT (EART): Results of a Multi-Institutional, Retrospective, Italian Study on 681Cases
Cozzarini, C
2145: Proctitis after 3D-Conformal Radiotherapy of Localized Prostate Cancer: Classification According to the Vienna Rectoscopy Score and Correlation to the EORTC/RTOG Score within the Austrian-German Multicenter Prostate Cancer Trial
Goldner, Gregor Click abstract title to view poster
2146: High Dose Rate Monotherapy for Prostate Cancer
Schour, Lionel
2147: Treatment of Localized Prostate Cancer with External Beam Radiation Therapy and High Dose Rate Interstitial Brachytherapy
Phan, Thinh
2148: Improved Understanding of Subtle Rectal Toxicity after Prostate Brachytherapy: Results with a Comprehensive ToxicityScoring System and Identification of Rectal Dosimetric Toxicity Predictors
Shah, Jinesh
2149: I-125 Versus Pd-103 for Low Risk Prostate Cancer: Morbidity Outcomes from a Prospective Randomized Multi-Center Controlled Trial
Herstein, Andrew
2150: PSA Kinetics following Prostate Brachytherapy: The PSA Bounce Phenomenon and Its Implications for PSA Doubling Time
Ciezki, Jay
2151: External Beam Radiation Dose Response and Toxicity in Low-Risk Prostate Cancer
Anderson, Carryn Click abstract title to view poster
2152: Phospho-AKT Expression and Prognosis of Locally Advanced Prostate Cancer: A Study Based on RTOG 8610
Zhai, G.
2153: First Report on the Clinical Use of Palladium-103 Coils: Safety and Efficacy in the Brachytherapy Treatment of Early Stage Prostate Cancer
Hartford, Alan
2154: Intensity Modulated Radiotherapy for High Risk Prostate Cancer based on Sentinel Node Optimized Target VolumeDefinition
Ganswindt, Ute
2155: Combination of Fast Neutron Irradiation and Permanent Prostate Brachytherapy in Intermediate and High Risk Localized Prostate Cancer
Perry, David
2156: Therapeutic Effects of Combination Radiation and Suicide Gene Therapy Using a Chimeric Adenovirus Vector for Bladder Cancer
Matsumoto, Kazumasa
2157: Preliminary Toxicity and Quality of Life (QoL) Data From a Randomized Phase III Trial Investigating the Optimal Method of Sequencing Radiation (XRT) and Short Course Total Androgen Blockade (TAB) in Prostate Cancer (PC)
Malone, Shawn Click abstract title to view poster
2158: Intraoperative Prostate Brachytherapy: Does Real-Time Ultrasound-Based Dosimetry Obviate The Need for Post Implant Dosimetric Analysis? A Retrospective Analysis of 1100 Patients Treated at Kaiser Permanente of Northen California
Mahmoudieh, Alireza
2159: Influence of Preimplant International Prostate Symptom Score on Urinary Morbidity Following Prostate Brachytherapy
Gutman, Sarah
2160: Does A Delay In Low Dose Rate (LDR) Brachytherapy After Tissue Diagnosis Affect Outcome For Men With Low RiskProstate Cancer?
Andrews, Stephen
2161: Pelvic Field Size and Biochemical Failure in the Treatment of Prostate Cancer: A Single Institution Experience
Soto, Daniel
2162: Sexual Function After Permanent Prostate Brachytherapy is Not Affected by Penile Bulb Dose
Simmons, John
2163: A Case-Control Study of Cluster Size as Predictor of Rectal Bleeding in T1-T2 Prostate Cancer Patients Treated by IMRT
Tucker, Susan Click abstract title to view poster
2164: Hyperthermia Combined with Radiation in Treatment of Locally Advanced Prostate Cancer is Associated with a Favorable Toxicity Profile
Hurwitz, Mark
2165: Rectal Doses Can Be Safely Minimized Without Affecting the Likelihood of Cure After Prostate Brachytherapy
Choi, Seungtaek
2166: Trends Analysis in 450 Patients Undergoing Permanent Prostate Brachytherapy Monotherapy with Iodine-125: Improvement in Rectal V100 and Decrease in Standard Deviation of D90
Wilson, Torrence
2167: The Impact of MRI Training on Improvement of CT Based Post Implant Dosimetry: A Six Physician Study
McLaughlin, Patrick
2168: Can U.S. Prostate Brachytherapy Results be Reproduced in Europe?
Khaksar, Sara Jane
2169: Prognostic Significance of Perineural Invasion on Biochemical Progression-Free Survival Following Prostate Brachytherapy
Galbreath, Robert
2170: Outcome and Toxicity of Patients with PSA Levels
Patel, Rajiv
2171: Shared Decision-Making in Prostate Cancer: Results of a Nationwide Interdisciplinary Consulting Service
Bottke, Dirk
2172: Does Hyperinsulinemia in Type-II Diabetes Mellitus Influence Disease Presentation and Long-Term Treatment Outcomes of Localized Prostate Cancer?
Nguyen, Khanh
2173: Assessing the Impact of MRI on Determination of Planning Volumes for Conformal Prostate Radiotherapy
Joon, Daryl Lim
2174: Pelvic Intensity Modulated Radiation Therapy for High Risk Prostate Cancer
Wahab, Sasha
2175: Improving Target (CTV) Delineation for Genitourinary (GU) Malignancies: A Novel Strategy Based on Anatomical and Functional Pelvic Nodal Pathways
Teh, Bin
2176: Target Volume Definition for Intensity Modulated Whole Pelvic Radiotherapy (IMWPRT)
Staffurth, John Click abstract title to view poster
2177: The Role of Neoadjuvant Androgen Suppression Therapy with Salvage Radiation Therapy after Radical Prostatectomy
Pai, Howard
2178: Quality of Life Following Prostate Brachytherapy- HRQol Returns to Baseline Within Nine Months
Henderson, Alastair
2179: Association of Statin Use with Local Control in Patients Treated with Selective Bladder Preservation for Muscle-Invasive Bladder Cancer
Tsai, Henry
2180: Proteomic Approaches to Identify Molecular Alterations in Androgen Independent Prostate Cancer and a Candidate Neuro-Endocrine Peptidase EP24.15
Swanson, Todd
2181: Daily Verification of Prostate Motion both with and without a Rectal Balloon (RB) Over the Course of Treatment
Canning, Christopher
2182: Cesium-131 Permanent Prostate Brachytherapy: An Initial Report
Prestidge, Bradley

Abstracts main page